登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C24H47NO3
化学文摘社编号:
分子量:
397.63
MDL number:
UNSPSC Code:
12352211
NACRES:
NA.25
SMILES string
OC[C@]([H])(NC(CCCCC)=O)[C@]([H])(O)/C=C/CCCCCCCCCCCCC
InChI
1S/C24H47NO3/c1-3-5-7-8-9-10-11-12-13-14-15-16-18-19-23(27)22(21-26)25-24(28)20-17-6-4-2/h18-19,22-23,26-27H,3-17,20-21H2,1-2H3,(H,25,28)/b19-18+
InChI key
NPRJSFWNFTXXQC-VHEBQXMUSA-N
assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 10 mg (860506P-10mg), pkg of 1 × 5 mg (860506P-5mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand
lipid type
sphingolipids
shipped in
dry ice
storage temp.
−20°C
General description
C6神经酰胺（d18:1/6:0）是一种具有细胞通透性的短链神经酰胺。它包含通过酰胺键与脂肪酰基链相连的氨基醇链。
Application
C6神经酰胺（d18:1/6:0）已被作为化疗药物用于测试其在乳腺癌细胞和卵巢癌细胞系中的抗肿瘤作用。它还被用于测试癌细胞中的化疗增敏作用。
Biochem/physiol Actions
C6神经酰胺（d18:1/6:0）可参与到增殖抑制和细胞凋亡诱导。当与酸性神经酰胺酶抑制剂DM102，即[(2R,3Z)-N-(1-羟基十八烷基-3-en-2-基）新戊酰酰胺]结合使用时，可有助于人乳腺癌细胞系的细胞死亡。C6神经酰胺可作为化疗的一种辅助手段。它可通过AKT（丝氨酸/苏氨酸特异性蛋白激酶）去磷酸化和α-微管蛋白乙酰化引发抗肿瘤作用。
Packaging
5 mL琥珀色玻璃螺旋盖小瓶（860506P-10mg）
5 mL琥珀色玻璃螺旋盖小瓶（860506P-5mg）
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Mechanisms involved in exogenous C2-and C6-ceramide-induced cancer cell toxicity
Fillet M, et al.
Biochemical Pharmacology, 65(10), 1633-1642 (2003)
Short-chain C6 ceramide sensitizes AT406-induced anti-pancreatic cancer cell activity
Zhao X, et al.
Biochemical and Biophysical Research Communications, 479(2), 166-172 (2016)
C6 ceramide dramatically enhances docetaxel-induced growth inhibition and apoptosis in cultured breast cancer cells: a mechanism study
Yang L, et al.
Experimental Cell Research, 332(1), 47-59 (2015)
C Ji et al.
Oncogene, 29(50), 6557-6568 (2010-08-31)
New chemotherapy-enhancing strategies are needed for better cancer therapy. Previous studies suggest that exogenous cell-permeable C6 ceramide may be a useful adjunct to the anti-tumor effects of chemotherapeutic agents (such as Taxol) against multiple cancers. Here we demonstrate that exogenous
C6-ceramide synergistically potentiates the anti-tumor effects of histone deacetylase inhibitors via AKT dephosphorylation and alpha-tubulin hyperacetylation both in vitro and in vivo
Zhu QY, et al.
Cell Death & Disease, 2(1), e117-e117 (2011)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持